Ambea
Market Cap
kr6.6b
Last Updated
2019/10/11 22:42 UTC
Data Sources
Company Financials +
Executive Summary
Ambea AB (publ), through its subsidiaries, primarily provides residential care services for people with disabilities and elderly care in Sweden and Norway.
Snowflake
Fundamentals
Good value with reasonable growth potential.
Similar Companies
Share Price & News
How has Ambea's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
-1.4%
AMBEA
2.0%
SE Healthcare
2.9%
SE Market
1 Year Return
-12.9%
AMBEA
-9.1%
SE Healthcare
9.0%
SE Market
Return vs Industry: AMBEA underperformed the Swedish Healthcare industry which returned -9.1% over the past year.
Return vs Market: AMBEA underperformed the Swedish Market which returned 9% over the past year.
Share holder returns
| AMBEA | Industry | Market | |
|---|---|---|---|
| 7 Day | -1.4% | 2.0% | 2.9% |
| 30 Day | -5.6% | -0.03% | -0.4% |
| 90 Day | 3.1% | 2.0% | 0.3% |
| 1 Year | -11.5%-12.9% | -7.9%-9.1% | 13.7%9.0% |
| 3 Year | n/a | -20.6%-24.4% | 30.5%11.1% |
| 5 Year | n/a | 170.2%131.7% | 66.0%30.7% |
Price Volatility Vs. Market
How volatile is Ambea's share price compared to the market and industry in the last 5 years?
Simply Wall St News
16 hours ago | Simply Wall St
What Kind Of Investor Owns Most Of Ambea AB (publ) (STO:AMBEA)?1 week ago | Simply Wall St
Is Ambea AB (publ) (STO:AMBEA) Trading At A 47% Discount?3 weeks ago | Simply Wall St
Brief Commentary On Ambea AB (publ)'s (STO:AMBEA) FundamentalsValuation
Is Ambea undervalued based on future cash flows and its price relative to the stock market?
48%
Discount to future cash flow value
Intrinsic Value Based on Future Cash Flows
Undervalued: AMBEA (SEK69.6) is trading below our estimate of fair value (SEK133.98)
Significantly Undervalued: AMBEA is trading below fair value by more than 20%.
Price Based on Earnings
PE vs Industry: AMBEA is good value based on its PE Ratio (26.2x) compared to the Healthcare industry average (26.7x).
PE vs Market: AMBEA is poor value based on its PE Ratio (26.2x) compared to the Swedish market (16.7x).
Price Based on Expected Growth
Low PEG Ratio: AMBEA is good value based on its PEG Ratio (0.6x)
Price Based on Value of Assets
PB vs Industry: AMBEA is overvalued based on its PB Ratio (1.4x) compared to the SE Healthcare industry average (1.4x).
Next Steps
Future Growth
How is Ambea expected to perform in the next 1 to 3 years based on estimates from 4 analysts?
45.3%
Forecasted annual earnings growth
Earnings and Revenue Growth Estimates
Future Annual Growth Analysis
Earnings vs Savings Rate: AMBEA's forecast earnings growth (45.3% per year) is above the savings rate (0.4%).
Earnings vs Market: AMBEA's earnings (45.3% per year) are forecast to grow faster than the Swedish market (8.7% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: AMBEA's revenue (11.5% per year) is forecast to grow faster than the Swedish market (4.5% per year).
High Growth Revenue: AMBEA's revenue (11.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Estimates
Future Return on Equity
High Future ROE: AMBEA's Return on Equity is forecast to be low in 3 years time (12.5%).
Next Steps
Past Performance
How has Ambea performed over the past 5 years?
32.9%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: AMBEA's earnings have grown significantly by 32.9% per year over the past 5 years.
Accelerating Growth: AMBEA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: AMBEA had negative earnings growth (-40.7%) over the past year, making it difficult to compare to the Healthcare industry average (-15.7%).
Return on Equity
High ROE: AMBEA's Return on Equity (4.7%) is considered low.
Return on Assets
ROA vs Industry: AMBEA's Return on Assets is below or equal to the Healthcare industry average last year.
Return on Capital Employed
ROCE Improving: AMBEA's Return on Capital Employed has declined over the past 3 years.
Next Steps
Financial Health
How is Ambea's financial position?
Financial Position Analysis
Short Term Liabilities: AMBEA's short term assets (SEK1.9B) do not cover its short term liabilities (SEK3.7B)
Long Term Liabilities: AMBEA's short term assets (1.9B) do not cover its long term liabilities (6.3B)
Debt to Equity History and Analysis
Debt Level: AMBEA's debt to equity ratio (95.5%) is considered high
Reducing Debt: Insufficient data to determine if AMBEA's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: AMBEA's debt is not well covered by operating cash flow (13.3%).
Interest Coverage: AMBEA's interest payments on its debt are well covered by EBIT (4.5x coverage).
Balance Sheet
Inventory Level: AMBEA has a high level of physical assets or inventory.
Debt Coverage by Assets: AMBEA's debt is not covered by short term assets (assets are 0.5x debt).
Next Steps
Dividend
What is Ambea's current dividend yield, its reliability and sustainability?
1.98%
Expected Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Dividend Yield and Payments Analysis
Notable Dividend: AMBEA's dividend (1.58%) isn’t notable compared to the bottom 25% of dividend payers in the Swedish market (1.8%).
High Dividend: AMBEA's dividend (1.58%) is low compared to the top 25% of dividend payers in the Swedish market (4.84%).
Stable Dividend: Too early to tell whether AMBEA's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if AMBEA's dividend payments are increasing as they only just started paying a dividend.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (41.4%), AMBEA's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: AMBEA's dividends in 3 years are forecast to be well covered by earnings (25.1% payout ratio).
Next Steps
Management
What is the CEO of Ambea's salary, the management and board of directors tenure and is there insider trading?
2.8yrs
Average management tenure
CEO
Fredrik Gren (51yo)
7.7yrs
Tenure
kr9,141,257
Compensation
Mr. Fredrik Gren serves as the Chief Executive Officer and President of Ambea AB (Ambea) at Carema Care AB since February 1, 2012. Mr. Gren served as President of Ambea AB. He served as the Chief Executive ...
CEO Compensation Analysis
Compensation vs. Market: Insufficient data to establish whether Fredrik's total compensation is reasonable compared to companies of similar size in the Swedish market.
Compensation vs Earnings: Fredrik's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
Management Age and Tenure
2.8yrs
Average Tenure
56yo
Average Age
Experienced Management: AMBEA's management team is considered experienced (2.8 years average tenure).
Board Age and Tenure
3.5yrs
Average Tenure
60yo
Average Age
Experienced Board: AMBEA's board of directors are considered experienced (3.5 years average tenure).
Insider Trading
Insider Buying: AMBEA insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
| Entity | Individual |
| Role | Senior Key Executive Business Area Manager of Altiden |
| Shares | 2,000 |
| Max Price | kr71.00 |
| Entity | Individual |
| Shares | 7,000 |
| Max Price | kr70.20 |
| Entity | Individual |
| Role | Senior Key Executive Business Area Manager of Nytida |
| Shares | 500 |
| Max Price | kr69.90 |
| Entity | Individual |
| Role | Senior Key Executive Business Area Manager of Nytida |
| Shares | 1,363 |
| Max Price | kr69.90 |
| Entity | Individual |
| Role | Senior Key Executive Business Area Manager of Nytida |
| Shares | 947 |
| Max Price | kr69.90 |
| Entity | Individual |
| Role | Senior Key Executive Business Area Manager of Nytida |
| Shares | 90 |
| Max Price | kr69.50 |
| Entity | Individual |
| Role | Senior Key Executive Business Area Manager of Nytida |
| Shares | 3,000 |
| Max Price | kr76.00 |
Ownership Breakdown
Management Team
Magnus Åkerhielm (56yo)
Business Area Manager of Nytida
- Tenure: 1.8yrs
Fredrik Gren (51yo)
CEO & President
- Tenure: 7.7yrs
- Compensation: kr9.14m
Daniel Warnholtz (46yo)
Deputy CEO & CFO
- Tenure: 8.8yrs
Margareta Sööder (63yo)
Director of Human Resources
- Tenure: 0yrs
Eva Domanders (53yo)
Chief Executive Officer of Klara
- Tenure: 0yrs
Agneta Lindgren (62yo)
Temporary Head of Nytida
- Tenure: 2.8yrs
Ulla Tansen (60yo)
Business Area Head of Vardaga
- Tenure: 6.8yrs
Lena Freiholtz (64yo)
Head of Quality
- Tenure: 0yrs
Jacob Persson
Head of Investor Relations
- Tenure: 1.3yrs
Miriam Toft (53yo)
Business Area Manager of Altiden
- Tenure: 0.8yrs
Board Members
Lars Gatenbeck (63yo)
Director
- Tenure: 1.4yrs
- Compensation: kr175.52k
Liselott Kilaas (60yo)
Director
- Tenure: 0.4yrs
Gunilla Rudebjer (60yo)
Director
- Tenure: 3.2yrs
- Compensation: kr400.00k
Mikael Stöhr (49yo)
Director
- Tenure: 1.4yrs
- Compensation: kr175.52k
Anders Bengt Borg (43yo)
Director
- Tenure: 5.8yrs
- Compensation: kr365.00k
Lena Hofsberger (65yo)
Chairperson
- Tenure: 6.8yrs
- Compensation: kr905.67k
Daniel Björklund (38yo)
Director
- Tenure: 0.4yrs
- Compensation: kr133.21k
Patricia Rodriguez
Employee Representative Director
- Tenure: 3.8yrs
Haralampos Kalpakas
Employee Representative Director
- Tenure: 3.8yrs
Magnus Sällström
Employee Representative Director
- Tenure: 3.8yrs
Company Information
Ambea AB (publ)'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Ambea AB (publ)
- Ticker: AMBEA
- Exchange: OM
- Founded: 1996
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: kr6.578b
- Shares outstanding: 94.51m
- Website: https://www.ambea.com
Number of Employees
Location
- Ambea AB (publ)
- Evenemangsgatan 21, 6 tr
- Box 1565
- Solna
- Stockholm County
- 171 29
- Sweden
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 0RNX | LSE (London Stock Exchange) | Yes | Ordinary Shares | GB | SEK | Mar 2017 |
| AMBEA | OM (OMX Nordic Exchange Stockholm) | Yes | Ordinary Shares | SE | SEK | Mar 2017 |
| AMBEAS | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Ordinary Shares | GB | SEK | Mar 2017 |
| 6MA | DB (Deutsche Boerse AG) | Yes | Ordinary Shares | DE | EUR | Mar 2017 |
Biography
Ambea AB (publ), through its subsidiaries, primarily provides residential care services for people with disabilities and elderly care in Sweden and Norway. The company operates through four segments: Varda ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/11 22:42 |
| End of Day Share Price | 2019/10/11 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.